Complications Following Stereotactic Needle Biopsy of Intracranial Tumors
- PMID: 26008141
- DOI: 10.1016/j.wneu.2015.05.025
Complications Following Stereotactic Needle Biopsy of Intracranial Tumors
Abstract
Background: Data from single-institution studies suggest that perioperative complication rates after stereotactic needle brain biopsies range from 6% to 12%, with permanent morbidity and mortality ranging from 3.1% to 6.4% and 0% to 1.7%, respectively. However, no population-level data are available. We conducted a population-based analysis to study complications after needle brain biopsy.
Methods: We analyzed patients recorded in the Nationwide Inpatient Sample who underwent stereotactic needle brain biopsy for neoplastic lesions between 2006 and 2012. A multivariate logistic model was used to identify factors associated with complications.
Results: We identified 7514 patients who underwent biopsy for various intracranial pathologies, including primary malignant neoplasm (52.3%), unspecified neoplasm (17.9%), metastasis (9.7%), meningioma (1.5%), radiation necrosis (0.8%), lymphoma (0.5%), and pineal region neoplasm (0.3%). Intracranial hemorrhage was the most frequent complication (5.8%). Other complications, including operative infection (0.1%) and wound breakdown (0.2%), were rare. Multivariate logistic regression analysis revealed that hemorrhage is associated with older age (reference <40 years; 40-59 years, odds ratio [OR] 2.26, 95% confidence interval [CI] 1.51-3.38; ≥60 years, OR 1.90, 95% CI 1.22-2.97), hydrocephalus (OR 3.02, 95% CI 2.20-4.14), and cerebral edema (OR 2.16, 95% CI 1.72-2.72). Hemorrhage is less likely when taking a biopsy from a primary malignant neoplasm (OR 0.73, 95% CI 0.59-0.90). Overall inpatient mortality after biopsy was 2.8%. Patients with intracranial hemorrhage were significantly more likely than patients without hemorrhage to die in the hospital (12.8% vs. 2.2%, P < 0.001) or be discharged to a rehabilitation/nursing facility (45.2% vs. 23.1%, P < 0.001).
Conclusions: Intracranial hemorrhage is the most frequent complication associated with needle brain biopsy and is associated with inpatient mortality and hospital disposition. Other complications are rare.
Keywords: Brain biopsy; Complications; Intracranial hemorrhage; Intracranial tumors; Stereotactic needle biopsy.
Copyright © 2015 Elsevier Inc. All rights reserved.
Comment in
-
Stereotactic Needle Biopsy: Sharpening the Tip.World Neurosurg. 2016 Jan;85:5. doi: 10.1016/j.wneu.2015.06.042. Epub 2015 Jul 2. World Neurosurg. 2016. PMID: 26141744 No abstract available.
Similar articles
-
Hemorrhage after stereotactic biopsy from intra-axial brain lesions: incidence and avoidance.J Neurol Surg A Cent Eur Neurosurg. 2014 May;75(3):177-82. doi: 10.1055/s-0032-1325633. Epub 2013 Mar 22. J Neurol Surg A Cent Eur Neurosurg. 2014. PMID: 23526202
-
Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies.Acta Neurochir (Wien). 2005 Jun;147(6):627-31; discussion 631. doi: 10.1007/s00701-005-0495-5. Epub 2005 Apr 15. Acta Neurochir (Wien). 2005. PMID: 15821863
-
Complications of MRI-guided stereotactic biopsy of brain lymphoma.Neuro Endocrinol Lett. 2014;35(7):613-8. Neuro Endocrinol Lett. 2014. PMID: 25617885
-
Morbidity of stereotactic biopsy for intracranial lesions.Kobe J Med Sci. 2011 Jan 21;56(4):E148-53. Kobe J Med Sci. 2011. PMID: 21937861 Review.
-
Patterns in neurosurgical adverse events: intracranial neoplasm surgery.Neurosurg Focus. 2012 Nov;33(5):E16. doi: 10.3171/2012.7.FOCUS12183. Neurosurg Focus. 2012. PMID: 23116096 Review.
Cited by
-
Unlocking the Potential of Circulating miRNAs as Biomarkers in Glioblastoma.Life (Basel). 2024 Oct 16;14(10):1312. doi: 10.3390/life14101312. Life (Basel). 2024. PMID: 39459612 Free PMC article. Review.
-
Comparison of diagnostic yields, operative times, and post-operative hemorrhage between twist drill versus burr hole craniotomy approaches for stereotactic needle brain biopsy.Neurosurg Rev. 2024 Oct 25;47(1):819. doi: 10.1007/s10143-024-03015-6. Neurosurg Rev. 2024. PMID: 39448506
-
-New frontiers in domain-inspired radiomics and radiogenomics: increasing role of molecular diagnostics in CNS tumor classification and grading following WHO CNS-5 updates.Cancer Imaging. 2024 Oct 7;24(1):133. doi: 10.1186/s40644-024-00769-6. Cancer Imaging. 2024. PMID: 39375809 Free PMC article. Review.
-
Establishing the utility of multi-platform liquid biopsy by integrating the CSF methylome and proteome in CNS tumours.J Neurooncol. 2024 Sep;169(2):233-239. doi: 10.1007/s11060-024-04695-2. Epub 2024 Aug 5. J Neurooncol. 2024. PMID: 39102117
-
Stereotactic biopsy for brain lesions: Doing more with less.J Neurosci Rural Pract. 2024 Jan-Mar;15(1):95-102. doi: 10.25259/JNRP_258_2023. Epub 2023 Oct 14. J Neurosci Rural Pract. 2024. PMID: 38476427 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
